132 related articles for article (PubMed ID: 18188713)
1. Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.
Cross DS; Burmester JK
Med Oncol; 2008; 25(1):40-9. PubMed ID: 18188713
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.
Liu W; Chen W; Zhang P; Yu C; Kong F; Deng J; Zhang J; Jiang A
Cell Mol Biol Lett; 2007; 12(4):482-92. PubMed ID: 17468839
[TBL] [Abstract][Full Text] [Related]
3. Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.
Cross D; Reding DJ; Salzman SA; Zhang KQ; Catalona WJ; Burke J; Burmester JK
Med Oncol; 2004; 21(2):145-53. PubMed ID: 15299187
[TBL] [Abstract][Full Text] [Related]
4. GDEP, a new gene differentially expressed in normal prostate and prostate cancer.
Olsson P; Bera TK; Essand M; Kumar V; Duray P; Vincent J; Lee B; Pastan I
Prostate; 2001 Sep; 48(4):231-41. PubMed ID: 11536302
[TBL] [Abstract][Full Text] [Related]
5. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
Noss KR; Wolfe SA; Grimes SR
Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
[TBL] [Abstract][Full Text] [Related]
8. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
9. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H
Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689
[TBL] [Abstract][Full Text] [Related]
10. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
Yu DC; Sakamoto GT; Henderson DR
Cancer Res; 1999 Apr; 59(7):1498-504. PubMed ID: 10197620
[TBL] [Abstract][Full Text] [Related]
11. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.
Pang S; Dannull J; Kaboo R; Xie Y; Tso CL; Michel K; deKernion JB; Belldegrun AS
Cancer Res; 1997 Feb; 57(3):495-9. PubMed ID: 9012480
[TBL] [Abstract][Full Text] [Related]
12. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
15. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Uchida A; O'Keefe DS; Bacich DJ; Molloy PL; Heston WD
Urology; 2001 Aug; 58(2 Suppl 1):132-9. PubMed ID: 11502468
[TBL] [Abstract][Full Text] [Related]
16. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
Pang S; Taneja S; Dardashti K; Cohan P; Kaboo R; Sokoloff M; Tso CL; Dekernion JB; Belldegrun AS
Hum Gene Ther; 1995 Nov; 6(11):1417-26. PubMed ID: 8573614
[TBL] [Abstract][Full Text] [Related]
17. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
[TBL] [Abstract][Full Text] [Related]
18. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
19. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
Zha S; Isaacs WB
Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter.
Cheng WS; Giandomenico V; Pastan I; Essand M
Endocrinology; 2003 Aug; 144(8):3433-40. PubMed ID: 12865322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
